Carregant...

Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent

Objective: To investigate changes in prescription practice during the first 3 years of post-marketing use of biological drugs, and to determine the proportion of patients who would not have received tumour necrosis factor (TNF) blocking agents if the prescription guidelines of the UK and the Netherl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hjardem, E, Hetland, M, Ostergaard, M, Krogh, N, Kvien, T
Format: Artigo
Idioma:Inglês
Publicat: 2005
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755604/
https://ncbi.nlm.nih.gov/pubmed/15640272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2004.031252
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!